{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:33Z","timestamp":1786119453447,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/mph.0b013e3181c2fd6d","type":"journal-article","created":{"date-parts":[[2010,2,27]],"date-time":"2010-02-27T01:03:30Z","timestamp":1267232610000},"page":"83-84","source":"Crossref","is-referenced-by-count":4,"title":["Current Controversies in Treating Invasive Zygomycosis"],"prefix":"10.1097","volume":"32","author":[{"given":"Oliver A.","family":"Cornely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210227","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MPH.0b013e3181c2bdce","article-title":"Reprot of a successful treatment of pulmonary cunninghamella bertholletiac infection with liposomal amphotericin and posaconazole in a child with GvFD and review of the literature","volume":"32","author":"Garbino","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"R2-1-20210227","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/JCM.00036-09","article-title":"Spectrum of zygomycete species identified in clinically significant specimens in the United States","volume":"47","author":"Alvarez","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R3-1-20210227","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11046-008-9098-z","article-title":"A case of cunninghamella bertholettiae Rhino-cerebral infection in a leukaemic patient and review of recent published studies","volume":"165","author":"Righi","year":"2008","journal-title":"Mycopathologia"},{"key":"R4-1-20210227","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R5-1-20210227","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2141.2009.07738.x","article-title":"ZYGOMYCOSIS: current approaches to management of patients with haematological malignancies","volume":"146","author":"Pagano","year":"2009","journal-title":"Br J Haematol"},{"key":"R6-1-20210227","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.bmt.1705754","article-title":"Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole","volume":"40","author":"Trifilio","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R7-1-20210227","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM200402263500923","article-title":"Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants","volume":"350","author":"Marty","year":"2004","journal-title":"New Engl J Med"},{"key":"R8-1-20210227","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/428780","article-title":"Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases","volume":"191","author":"Kontoyiannis","year":"2005","journal-title":"J Infect Dis"},{"key":"R9-1-20210227","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1086\/422723","article-title":"Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis","volume":"39","author":"Siwek","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R10-1-20210227","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1086\/423274","article-title":"Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole","volume":"39","author":"Imhof","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R12-1-20210227","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1182\/blood.V110.11.163.163","article-title":"Results of a randomized, double-blind trial of fluconazole vs. voriconazole for the prevention of invasive fungal infections in 600 allogeneic blood and marrow transplant patients","volume":"110","author":"Wingard","year":"2007","journal-title":"Blood"},{"key":"R13-1-20210227","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s15010-008-7357-z","article-title":"Aspergillus to zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections","volume":"36","author":"Cornely","year":"2008","journal-title":"Infection"},{"key":"R14-1-20210227","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1086\/505969","article-title":"Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries","volume":"43","author":"Ullmann","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R15-1-20210227","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00277-008-0622-5","article-title":"Treatment of invasive fungal infections in cancer patients\u2014recommendations of the infectious diseases working party (AGIHO) of the German society of hematology and oncology (DGHO)","volume":"88","author":"B\u00f6hme","year":"2009","journal-title":"Ann Hematol"},{"key":"R16-1-20210227","first-page":"207","article-title":"Mucormycosis in hematologic patients","volume":"89","author":"Pagano","year":"2004","journal-title":"Haematologica"},{"key":"R17-1-20210227","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R18-1-20210227","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/AAC.45.12.3487-3496.2001","article-title":"Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study","volume":"45","author":"Walsh","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"R20-1-20210227","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"Reed","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R21-1-20210227","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/599105","article-title":"Recent advances in the management of mucormycosis: from bench to bedside","volume":"48","author":"Spellberg","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R22-1-20210227","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e3181c2fd6d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:16:39Z","timestamp":1786040199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-201003000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3181c2fd6d","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}